Opportunity Overview
Доставка на лекарствен продукт Cerliponase alfa Международно непатентно наименование INN Cerliponase alfa Анатомо-терапевтичен код /АТС-код/ A16AB17 Лекарствена форма Solution for infusion Количество активно вещество 150 mg of cerliponase alfa in 5 ml of solution; 2 vials + 1 vial (Soution 5 ml (30 mg/ml) + Flushing solution 5 ml) Единична мярка комплект: 2 vials + 1 vial (Solution 5 ml (30 mg/ml) + Flushing solution 5ml) Прогнозно кличество за единица мярка: 60 | Доставка на лекарствен продукт Vosoritide 0.4 mg Международно непатентно наименование INN Vosoritide Анатомо-терапевтичен код /АТС-код/ M05BX07 Лекарствена форма Powder and solvent for solution for injection Количество активно вещество 0.4 mg powder and solvent for solution for injection,corresponding to a concentration of 0.8 mg/mL Единична мярка комплект: 1 флакон + предварително напълнена спринцовка + игла + спринцовка за приложение Прогнозно кличество за единица мярка 1400 | Доставка на лекарствен продукт Vosoritide 0.56 Международно непатентно наименование INN Vosoritide Анатомо-терапевтичен код /АТС-код/ M05BX07 Лекарствена форма Powder and solvent for solution for injection Количество активно вещество 0.56 mg powder and solvent for solution for injection,corresponding to a concentration of 0.8 mg/mL Единична мярка комплект: 1 флакон + предварително напълнена спринцовка + игла + спринцовка за приложение Прогнозно кличество за единица мярка 4900 | Доставка на лекарствен продукт Vosoritide 1.2 mg Международно непатентно наименование INN Vosoritide Анатомо-терапевтичен код /АТС-код/ M05BX07 Лекарствена форма Powder and solvent for solution for injection Количество активно вещество 1.2 mg powder and solvent for solution for injection,corresponding to a concentration of 2 mg/mL Единична мярка комплект: 1 флакон + предварително напълнена спринцовка + игла + спринцовка за приложение Прогнозно кличество за единица мярка 1950
Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.
Start FreeSolicitation Details
| Issuing agency | International buyer |
|---|---|
| Country | Bulgaria |
| Category | Pharmaceuticals |
| Estimated value | $7.8M |
| Published | August 28, 2026 |
| Procurement stage | Active solicitation |
| Closed | September 28, 2026 |
| Status | Closed — no longer accepting responses |
| Original language | Bulgarian — members read it in their own language |
| Official source | View original notice |
| Last verified | October 11, 2026 |
Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.
Browse Similar Open Opportunities in Bulgaria
See every Bulgaria Pharmaceuticals opportunity your competition is missing. Free for 14 days.
Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.
Start Free Trial — No Card RequiredFree 14-day trial · no card required
See who is already competing here →Get a free Bulgaria Pharmaceuticals intelligence report in your inbox
A personalized report on Bulgaria Pharmaceuticals opportunities, emailed in 5-10 minutes. One per month, no account needed.